Home › Esophageal Adenocarcinoma › Texas › Houston

Pag-aaral pangklinika para sa Esophageal Adenocarcinoma sa Houston, TX

Isang pag-aaral para sa Esophageal Adenocarcinoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Nagre-recruitPhase 2/3

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Ben Taub General Hospital, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06203600

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Nagre-recruitPhase 1

University of Texas MD Anderson Cancer Center, Houston
The University of Texas, MD Anderson Cancer Center - West Houston, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07090499

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Nagre-recruitPhase 2/3

University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07221149

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Nagre-recruitPhase 1/2

The Methodist Hospital Research Institute, Houston
The University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06324357

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Nagre-recruitPhase 1

MD Anderson, Houston
NEXT Oncology Houston, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Nagre-recruit

The University of Texas MD Anderson Cancer Center, Houston

Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05753748

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Nagre-recruitPhase 3

Research Site, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07431281

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Nagre-recruitPhase 1

Normunity Investigational Site, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07182149

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Nagre-recruitPhase 1

Oncology Consultants, PA, Houston
Oncology Consultants, PA., Houston
The University of Texas M.D. Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04389632

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1

MDACC, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update May 8, 2026 · NCT05954312

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT03161522

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Nagre-recruitPhase 2

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2025 · NCT05563766

Pag-aaral para sa Esophageal Adenocarcinoma sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.